4.8 Article

TRAIL-R as a negative regulator of innate immune cell responses

Journal

IMMUNITY
Volume 21, Issue 6, Pages 877-889

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2004.11.008

Keywords

-

Categories

Funding

  1. NCI NIH HHS [CA92000] Funding Source: Medline

Ask authors/readers for more resources

TRAIL receptor (TRAIL-R) signaling has been implicated in inducing apoptosis in tumor cells, but little is understood about its physiological function. Here, we report the generation and characterization of TRAILR(-1-) mice, which develop normal lymphocyte populations but possess enhanced innate immune responses. TRAIL-R-1- mice exhibited increased clearance of murine cytomegalovirus that correlated with increased levels of IL-12, IFN-alpha., and IFN-gamma. Stimulation of macrophages with Mycobacterium and Toll-like receptor (TLR)-2, -3, and -4, but not TLR9, ligands resulted in high levels of TRAIL upregulation and enhanced cytokine production in TRAIL-R-1- cells. The immediate early TLR signaling events in TRAIL-R-1- macrophages and dendritic cells are normal, but IkappaB-alpha homeostatic regulation and NF-kappaB activity at later time points is perturbed. These data suggest that TRAIL-R negatively regulates innate immune responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available